The Lattice (Official 3DHEALS Podcast)

Episode #108 | Teleporting Medicine with 3D Printing - Dr. Stephen Ryan, PolyUnity

What happens when a hospital needs a simple part but the supply chain takes weeks or months to deliver it? Dr. Stephan Ryan, physician and co-founder of PolyUnity, set out to solve that problem by helping hospitals produce parts themselves through safe, compliant 3D printing. In this episode, Stephen Ryan shares how early clinical experiences and an academic 3D printing lab evolved into a platform designed to help hospitals manufacture equipment on demand. The COVID pandemic accelerated that vision, exposing major supply chain gaps and pushing the team to rapidly scale production. Stephen Ryan explains how those lessons shaped PolyUnity’s approach to building practical additive manufacturing systems within the realities of healthcare procurement, regulation, and hospital workflows. Show notes: https://3dheals.com/teleporting-medicine-with-3d-printing-dr-stephen-ryan-of-polyunity-interview/Full video interview: https://youtu.be/cO7mTr5GLJ8?si=icmU03OI1cPDZJL9About our guest: Dr. Stephen Ryan is a physician, entrepreneur, and the co-founder and Chief Medical Officer of PolyUnity, a Canadian health tech company focused on lowering the barrier for hospitals to adopt 3D printing through its i3D platform and solutions. His work centers on building software, quality systems, and distributed print capacity so that hospitals can reliably order and receive end use 3D printed parts, from simple fixtures to clinically relevant devices, within existing procurement and regulatory frameworks.Send a textSupport the showSubscribe to our premium version and support the show. Follow us: Twitter Instagram Linkedin 3DHEALS WebsiteFacebookFacebook GroupYoutube channelAbout Pitch3D

Episode#107 | The Lattice Feb 2026 - Latest News in Healthcare 3D Printing

We map the biggest shifts in healthcare 3D printing this month, from emissions safety to custom eyewear, implant surfaces, microfluidics, and space-based biomanufacturing. We weigh promise against risk and share where standards and design can close the gap.• emissions from desktop and industrial printers and why they matter • safeguards for vulnerable groups and safer materials and testing • face-scan eyewear, on-demand manufacturing, and fashion collaborations • implant surface roughness, porosity, coatings, and clinical outcomes • ceramic, titanium, and PEEK devices for spine, ankle, and CMF • microfluidics for diagnostics and microneedle vaccines and immunotherapy • digital microfluidics and 3D cell culture for faster R&D • microgravity biomanufacturing and what space enables for medicineSee blog post related to this podcast: https://3dheals.com/the-lattice-feb-2026-advanced-devices-custom-eyewear-and-hidden-health-risks-of-3d-printing/Send a textSupport the showSubscribe to our premium version and support the show. Follow us: Twitter Instagram Linkedin 3DHEALS WebsiteFacebookFacebook GroupYoutube channelAbout Pitch3D

Episode #106| Bionic Hands For Humans and Robots: The Psyonic Story

We share how a decade of soft robotics, open APIs, and relentless iteration turned a 3D-printed prototype into a durable, touch-sensing bionic hand used by amputees and robots. Stories of failure, funding, and firsts reveal how speed, sensation, and design choices translate to real lives and real factories.• early 3D printing wins and durability limits• shift to soft robotics, silicone overmolding, carbon fiber reinforcement• founding spark, Ecuador trial, and move from academia to company• SBIR lifeline, failed crowdfunding, then coverage and clinical validation• speed, grip force, and touch sensors compared with the market• open API for control and data streaming in minutes• robotics crossover in automotive and research labs• access initiatives via the Ability Fund and global impact• manufacturing scale plans and ethical boundaries• practical founder habits, grit, and advice to start nowPlease listen to the disclaimer at the end of this podcastShow notes: https://3dheals.com/aadeel-akhtar-bionic-hands-for-humans-and-robots-the-psyonic-story/YouTube: https://youtu.be/mDVMRhjXr0w?si=qoZrScjaC6nbiPMJAbout our guest:Dr. Aadeel Akhtar, CEO of PSYONIC, founded the company to create advanced, accessible bionic limbs after meeting a young girl in Pakistan who was missing a limb. PSYONIC's bionic Ability Hand is the fastest on the market, impact-resistant, and the first to provide a sense of touch. It is also covered by Medicare and is being used by humans and robotics companies globally, including NASA, Meta, Mercedes, and Google. Dr. Akhtar earned a Ph.D. in Neuroscience and an M.S. in Electrical & Computer Engineering from the University of Illinois, along with a B.S. in Biology and an M.S. in Computer Science from Loyola University Chicago. He’s been recognized by MIT Technology Review and Newsweek and secured a 3-shark deal on Shark Tank. Send a textSupport the showSubscribe to our premium version and support the show. Follow us: Twitter Instagram Linkedin 3DHEALS WebsiteFacebookFacebook GroupYoutube channelAbout Pitch3D

Episode #105 | Jan 2026 News: ARPA-H Organ "Moonshots", Point-of-Care Manufacturing, and More

We track a month of fast-moving news in healthcare 3D printing, from organ-scale bioprinting programs and ARPA-H’s funding model to point-of-care tools already entering clinics. The throughline is clear: vascularization, immune compatibility, and scale are converging with real-world deployment.• UT Southwestern’s organoid-plus-bioprinting strategy for durable liver tissue• Carnegie Mellon’s consortium on vascularization, immune control, and scale• ARPA-H’s moonshot funding model is accelerating medical innovation• Aspect Biosystems and Novo Nordisk’s bet on curing diabetes• Cost shift from chronic management to curative therapies• Near-term point-of-care printing: Curify Labs and AZORG integrations• Key milestone to watch: functional vascular networks• Outlook as research, industry, and funding alignRemember, this podcast is for educational and informational purposes onlyThe views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professionalShownotes: https://3dheals.com/lattice-news-arpa-h-organ-moonshots-point-of-care-manufacturing-and-more/Send a textSupport the showSubscribe to our premium version and support the show. Follow us: Twitter Instagram Linkedin 3DHEALS WebsiteFacebookFacebook GroupYoutube channelAbout Pitch3D

Episode #104| 3DHEALS2026 JP Morgan San Francisco (Live Recording) - Invest in 3D

A crowded JP Morgan week can blur into noise, so we built a quieter stage to focus on what actually moves healthcare forward: 3D software‑planned care, on‑demand manufacturing, and proof that patients and payers can feel. Recorded live in San Francisco, this special episode brings founders and investors together to show how 3D data and advanced manufacturing are turning personalization into a scalable, measurable reality.We start with a rare blueprint for value in spine surgery: virtual planning, patient‑specific 3D printed implants, and post‑op analytics that cut two‑year reoperations by 74% while compressing lead times from eight weeks to eight days. From there, the conversation widens fast. Hear how microarray patches with five‑micron precision enable co‑delivery without co‑formulation and factory‑level scale; how therapeutic hardware draws on bone biology to reduce revisions; how personalized pessaries bring dental‑style business models to women’s health; and how drill‑free, patient‑specific dental implants fit in six days without a single turn of a drill.We also explore the frontier where human recovery meets robotics. A single bionic hand platform serves amputees and humanoid robots, translating human manipulation data into industrial automation while staying Medicare‑covered. On the R&D side, vascularized tissues and cryobioprinted models aim to fix translational failure by making complex biology reproducible and shippable. Structural biopolymer fibers unlock sutures, meshes, and sports medicine implants with clean‑room scale. A countertop system automates cell therapy final formulation so community hospitals can treat more patients safely. And a new biomanufacturing approach targets IVIG supply constraints by achieving human‑like B‑cell densities in ultrafast 3D printed bioreactors. We close with high‑viscosity inkjet that prints materials traditional jets can’t, powering durable dental parts and microneedle patches at true production speeds.Along the way, an investor panel compares notes on 2026: where exits might return, where non‑dilutive capital is shifting, and what it now takes to earn a check—clear end‑user value, defensible tech, and a distribution edge. If you care about medtech, bioprinting, cell and gene therapy delivery, or the future of personalized care, this is your field guide to what’s working right now.If this conversation sparks new ideas or a partnership you want to pursue, subscribe, share the episode with a colleague, and leave a quick review telling us which breakthrough you want to hear more about.Event speaker biographies: https://3dheals.com/life-in-3d-investing-in-the-next-frontier/On-Demand Video (Pending publication): https://3dheals.com/courses/Pitch 3D Application link: https://3dheals.com/pitch3d/Send a textSupport the showSubscribe to our premium version and support the show. Follow us: Twitter Instagram Linkedin 3DHEALS WebsiteFacebookFacebook GroupYoutube channelAbout Pitch3D